Stay updated with breaking news from Collective Coordinates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProMIS Neurosciences, Inc. (NASDAQ:PMN – Free Report) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 200 shares, a decrease of 33.3% from the May 31st total of 300 shares. Based on an average daily volume of 3,300 shares, the short-interest ratio is […]
TORONTO, Ontario and CAMBRIDGE, Massachusetts - - ProMIS Neurosciences Inc. (TSX: PMN) (NASDAQ: PMNRFXF) (
ProMIS Neurosciences, Inc. (TSE:PMN – Get Rating)’s stock price rose 0.7% during mid-day trading on Monday . The company traded as high as C$7.10 and last traded at C$7.05. Approximately 227 shares were traded during trading, a decline of 88% from the average daily volume of 1,917 shares. The stock had previously closed at C$7.00. […]
TORONTO, Ontario and CAMBRIDGE, Massachusetts - - ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded... | May 16, 2023
15.05.2023 - Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in Alzheimer’s diseasePresented preclinical data supporting target identification and candidate differentiation across pipeline of antibody ...